Literature DB >> 16633570

Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I.

Hairuo Peng1, Dora Carrico, Van Thai, Michelle Blaskovich, Cynthia Bucher, Erin E Pusateri, Said M Sebti, Andrew D Hamilton.   

Abstract

A series of compounds based on the carboxyl-terminal CAAL sequence of PGGTase-I substrates was designed and synthesized. Using piperazin-2-one as a semi-rigid scaffold, we have introduced critical pharmacophores in a well-defined arrangement to mimic the CAAL sequence. High potency and exceptional selectivity were obtained for inhibition of PGGTase-I with structures such as 45 and 70. Potency of this series of GGTIs was dependent on the presence of an L-leucine residue with a free carboxyl terminus, as well as an S configuration of the 3-aryl group. The selectivity was significantly enhanced by 5-methyl substitution on the imidazole ring and fluorine substitution on the 3-aryl group. Modification of the 6-position of the piperazinone scaffold was found to be unfavorable. Compounds 44 and 69, the corresponding methyl esters of 45 and 70, were found to selectively block processing of Rap1A by PGGTase-I in whole cells with IC(50) values of 0.4 microM and 0.7 microM respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633570     DOI: 10.1039/b517572k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  10 in total

1.  Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors.

Authors:  Aslamuzzaman Kazi; Shengyan Xiang; Hua Yang; Liwei Chen; Perry Kennedy; Muhammad Ayaz; Steven Fletcher; Christopher Cummings; Harshani R Lawrence; Francisca Beato; Ya'an Kang; Michael P Kim; Andrea Delitto; Patrick W Underwood; Jason B Fleming; Jose G Trevino; Andrew D Hamilton; Said M Sebti
Journal:  Clin Cancer Res       Date:  2019-06-21       Impact factor: 12.531

2.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

3.  Synthesis and evaluation of 3- and 7-substituted geranylgeranyl pyrophosphate analogs.

Authors:  Michelle Maynor; Sarah A Scott; Emily L Rickert; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2008-02-12       Impact factor: 2.823

4.  Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

Authors:  Joshua D Ochocki; Mark D Distefano
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

Review 5.  Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.

Authors:  Aleksandra Marchwicka; Daria Kamińska; Mohsen Monirialamdari; Katarzyna M Błażewska; Edyta Gendaszewska-Darmach
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

6.  A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.

Authors:  Thomas B Karasic; E Gabriela Chiorean; Said M Sebti; Peter J O'Dwyer
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

7.  Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation.

Authors:  Yuri K Peterson; Xiang S Wang; Patrick J Casey; Alexander Tropsha
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

8.  Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy.

Authors:  Aslamuzzaman Kazi; Adam Carie; Michelle A Blaskovich; Cynthia Bucher; Van Thai; Stacy Moulder; Hairuo Peng; Dora Carrico; Erin Pusateri; Warren J Pledger; Norbert Berndt; Andrew Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2009-02-09       Impact factor: 4.272

9.  Mechanistic investigation of aziridine aldehyde-driven peptide macrocyclization: the imidoanhydride pathway.

Authors:  Serge Zaretsky; Jennifer L Hickey; Joanne Tan; Dmitry Pichugin; Megan A St Denis; Spencer Ler; Benjamin K W Chung; Conor C G Scully; Andrei K Yudin
Journal:  Chem Sci       Date:  2015-07-07       Impact factor: 9.825

10.  Regioselective addition of Grignard reagents to N-acylpyrazinium salts: synthesis of substituted 1,2-dihydropyrazines and Δ5-2-oxopiperazines.

Authors:  Valentine R St Hilaire; William E Hopkins; Yenteeo S Miller; Srinivasa R Dandepally; Alfred L Williams
Journal:  Beilstein J Org Chem       Date:  2019-01-08       Impact factor: 2.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.